- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Seres Therapeutics Inc (MCRB)
NASDAQ
Currency in USD
Disclaimer
0.8485
+0.0113(+1.19%)
Closed
After Hours
0.8570+0.0085(+1.0018%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.8300
0.8646
52 wk Range
0.5400
2.0500
MCRB Scorecard
Full Analysis
Operates with a significant debt burden
"Seres Therapeutics Inc stock price live, this page displays NASDAQ MCRB stock exchange data. View the MCRB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Seres Therapeutics Inc real time stock price chart below.
What Is the Seres Therapeutics Inc Stock Price Today?
The Seres Therapeutics Inc stock price today is 0.8485.
What Is the Stock Symbol for Seres Therapeutics Inc?
The stock symbol for Seres Therapeutics Inc is ""MCRB.""
What Stock Exchange Does Seres Therapeutics Inc Trade On?
Seres Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Seres Therapeutics Inc a Good Stock to Buy?
Determining whether Seres Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MCRB quote. (ISIN: US81750R1023)"
What Is the Seres Therapeutics Inc Stock Price Today?
The Seres Therapeutics Inc stock price today is 0.8485.
What Is the Stock Symbol for Seres Therapeutics Inc?
The stock symbol for Seres Therapeutics Inc is ""MCRB.""
What Stock Exchange Does Seres Therapeutics Inc Trade On?
Seres Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Seres Therapeutics Inc a Good Stock to Buy?
Determining whether Seres Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MCRB quote. (ISIN: US81750R1023)"
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.83000.8646
52 wk Range
0.54002.0500
UnlockMCRB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
3.3375
Upside
+293.3412%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
4 analysts have revised their earnings upwards for the upcoming period
Seres Therapeutics Inc Company Profile
Seres Therapeutics, Inc., a microbiome therapeutics company, develop microbiome therapeutics to treat the modulation of the colonic microbiome. It develops a novel class of biological drugs that are designed to treat by modulating the microbiome to restore health by repairing the function of a disrupted microbiome to a non-disease state. The company’s lead product candidate is VOWST, an oral microbiome therapeutic that has completed Phase III clinical trial for the treatment of recurrent Clostridioides difficile infection. Its product pipeline also includes SER-155, an investigational oral fermented microbiome therapeutic which is in Phase 1b clinical trials for the treatment of gastrointestinal infections, bacteremia, and graft versus host disease in immunocompromised patients including patients receiving allogeneic hematopoietic stem cell transplantation. In addition, the company engages in the development of SER-287 which is in Phase 2b and SER-301 that is in Phase 1b to treat ulcerative colitis. Further, it has license Agreement with NHSc Rx License GmbH for the therapeutic products based on the microbiome technology, which includes VOWST product candidate, which is developed for the treatment of CDI and recurrent CDI; and collaboration license agreement with Société des Produits Nestlé S.A. (Nestlé) for the development and commercialization of certain product candidates for the treatment and management of CDI and inflammatory bowel disease including UC and Crohn’s disease. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.
Compare MCRB to Peers and Sector
Metrics to compare | MCRB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMCRBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.8x | −4.5x | −0.6x | |
PEG Ratio | −0.18 | −0.05 | 0.00 | |
Price/Book | −1.5x | 4.0x | 2.6x | |
Price / LTM Sales | 344.2x | 8.0x | 3.2x | |
Upside (Analyst Target) | 38.5% | 230.6% | 40.8% | |
Fair Value Upside | Unlock | 15.7% | 5.9% | Unlock |
FAQ
What Is the Seres Therapeutics Inc (MCRB) Stock Price Today?
The Seres Therapeutics Inc stock price today is 0.8485
What Stock Exchange Does Seres Therapeutics Inc Trade On?
Seres Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Seres Therapeutics Inc?
The stock symbol for Seres Therapeutics Inc is "MCRB."
What Is the Seres Therapeutics Inc Market Cap?
As of today, Seres Therapeutics Inc market cap is 128.74M.
What is Seres Therapeutics Inc Earnings Per Share?
The Seres Therapeutics Inc EPS is -1.17.
What Is the Next Seres Therapeutics Inc Earnings Date?
Seres Therapeutics Inc will release its next earnings report on 05 Nov 2024.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.